Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001817048-22-000002
Filing Date
2022-05-19
Accepted
2022-05-19 09:15:25
Documents
1
Effectiveness Date
2022-05-19
Items
Item 06c:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 12641
  Complete submission text file 0001817048-22-000002.txt   13663
Mailing Address 201 DAM TRAIL #1349 LINVILLE NC 28646
Business Address 201 DAM TRAIL #1349 LINVILLE NC 28646 347-967-6831
Gilgamesh Pharmaceuticals, Inc. (Filer) CIK: 0001817048 (see all company filings)

EIN.: 842552195 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-446192 | Film No.: 22941267